Skip to main content
. 2023 Jun 30;14:1177403. doi: 10.3389/fimmu.2023.1177403

Figure 1.

Figure 1

Comparison of the cut-off values for inflammatory biomarkers on overall survival (OS) and relapse-free survival (RFS) in patients with ovarian cancer.